News - Rousselot Biomedical

Rousselot® Biomedical announces the world's first GMP grade GelMA

Rousselot®, Darling Ingredients’ health brand, and the global leader of collagen-based solutions1 announces the launch of GMP grade GelMA. X-Pure® GelMA is the first gelatin methacryloyl, or GelMA, on…

Apr 13

Biomedical , rousselot

Rousselot Announces Partnership with Terasaki Institute for Biomedical Innovation

Rousselot® today announced that it has partnered with the Terasaki Institute for Biomedical Innovation (TIBI), a California-based research institute focused on regenerative medicine.

Jan 12

Biomedical , rousselot

New study confirms that purity and type of coating biomaterials used in 2D cell culturing are crucial for efficient stem cell proliferation

X-Pure® gelatin outperformed standard research grade gelatins and other coating materials in 2D cell culturing

Dec 09

Biomedical , rousselot

Zerion Pharma extends its licensing agreement with Rousselot B.V to exploit Dispersome® technology platform

Rousselot B.V. and Zerion Pharma ApS announce today that they have strengthened their partnership through an extension of an exclusive license agreement entered into in 2019.

Nov 25

sponge powder and compact, with Quali Pure

Biomedical , rousselot

Rousselot® Biomedical launches Quali-Pure™

Rousselot® Biomedical launches Quali-Pure™, a range of gelatins with controlled purity, supporting full compliance with new EU Medical Device Regulations and ISO 22442

Oct 19

Biomedical , rousselot

Antleron-Rousselot® collaborate to develop X-Pure®–by-Design

Rousselot and Antleron announce collaboration. Rousselot offers customizable, ultra-pure gelatins and collagens to the biomedical market while Antleron is an ecosystem R&D company providing…

Oct 12